Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (17)

2023

  1. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2022

  1. Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment battery

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 8, Núm. 4

2021

  1. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol

    Frontiers in Neurology, Vol. 12

2020

  1. Gene expression analysis of astrocyte and microglia endocannabinoid signaling during autoimmune demyelination

    Biomolecules, Vol. 10, Núm. 9, pp. 1-19

2017

  1. Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury

    Journal of Neuroinflammation, Vol. 14, Núm. 1

2015

  1. Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

    Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512

  2. FTY720 attenuates excitotoxicity and neuroinflammation

    Journal of Neuroinflammation, Vol. 12, Núm. 1

  3. Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154

2014

  1. Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology

    PLoS ONE, Vol. 9, Núm. 12

2013

  1. TNFRSF1A polymorphisms rs1800693 and rs4l49584 in patients with multiple sclerosis

    Neurology, Vol. 80, Núm. 22, pp. 2010-2016

2012

  1. Botulinum toxin A in chronic refractory migraine: Premarketing experience

    Revista de Neurologia, Vol. 55, Núm. 7, pp. 385-391

  2. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990

2011

  1. Gain-of-function of P2X7 receptor gene variants in multiple sclerosis

    Cell Calcium, Vol. 50, Núm. 5, pp. 468-472

  2. Increased expression of cystine/glutamate antiporter in multiple sclerosis

    Journal of Neuroinflammation, Vol. 8

2008

  1. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis

    Journal of Neuroimmunology, Vol. 195, Núm. 1-2, pp. 194-198

2007

  1. Excitotoxic damage to white matter

    Journal of Anatomy

  2. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis

    Journal of Neuroscience, Vol. 27, Núm. 35, pp. 9525-9533